Tracked deals
3
3 tracked deals across 2019-2021.
Operating Company
Healthcare
Allucent
Cary, North Carolina, United States
Formerly known as Allucent (formerly CATO SMS), CATO SMS, CATO SMS (Cato Research + SMS-oncology)
Allucent is a global provider of comprehensive drug development solutions, helping small and mid-sized biotech companies bring new therapies to light through consulting, clinical operations, biometrics, and clinical pharmacology.
- Focus Areas
- Clinical Pharmacology, Biostatistics / Biometrics, Clinical Trial Operations / CRO services
- Website
- www.allucent.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
2 buyout · 1 addon
Allucent Acquisition Volume by Year
Last 3 years
Supporting Data
Recent Transactions
-
- Buyer
- CATO SMS
- Target
- Nuventra, Inc.
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Type
- Buyout
CATO SMS has acquired Nuventra, a Durham, North Carolina–based clinical pharmacology science and services provider, to expand its drug development offering into clinical pharmacology, pharmacometrics and model‑informed drug development. The deal brings Nuventra's PK/PD, population PK/PD and biosimulation expertise into CATO SMS's existing regulatory, biostatistics and clinical trial services to reduce development risk, cost and timelines for biopharmaceutical clients.
-
September 15, 2020
- Buyer
- CATO SMS
- Target
- Array Biostatistics
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Type
- Addon
CATO SMS has acquired Wilmington, North Carolina–based Array Biostatistics to expand its biostatistical consulting, analysis and statistical programming capabilities. The acquisition is an add-on to the PE-backed CATO SMS platform and aims to broaden CATO SMS’ biometrics offering for small and emerging biopharmaceutical clients, particularly in oncology, rare/orphan indications and cell & gene therapy.
-
October 28, 2019
- Buyer
- Cato Research, LLC
- Target
- Specialized Medical Services-oncology BV (SMS-oncology)
- Industry
- Healthcare Services
- Location
- North Holland, Netherlands
- Type
- Buyout
Cato Research, LLC has merged with Specialized Medical Services-oncology BV (SMS-oncology); the combined company will transition to the name CATO SMS. The deal expands Cato's oncology and regulatory capabilities and broadens the combined company's presence across Europe and North America; financial terms were not disclosed.
Related Acquisition Pages
Selling a company? Get in front of buyers like Allucent
Turn tracked acquisition activity into an outreach-ready buyer list.